Roche reports very strong results in 2019
Group sales increase 9% at constant exchange rates and 8% in Swiss francs, driven by new products, more than compensating for impact of competition from biosimilars
Source: Roche Investor Update - Category: Pharmaceuticals Source Type: news
More News: Pharmaceuticals | Switzerland Health